SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-11 |
| Reported value | $603,308,468 |
| Positions | 27 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ARGENX SE | ARGX | SPONSORED ADR | $70,897,400 | 76,417 |
| ICON PUB LTD CO | ICLR | SHS | $53,527,521 | 308,143 |
| GUARDANT HEALTH INC | GH | COM | $45,111,771 | 300,685 |
| INSMED INC | INSM | COM PAR $.01 | $40,955,941 | 384,130 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | COM | $35,743,961 | 624,676 |
| ILLUMINA INC | ILMN | COM | $32,952,828 | 187,413 |
| SCHOLAR ROCK HLDG CORP | SRRK | COM | $30,539,960 | 555,272 |
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | $30,439,311 | 248,322 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | COM | $29,520,800 | 884,121 |
| COMPASS PATHWAYS PLC | CMPS | SPONSORED ADS | $29,155,042 | 2,060,427 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.